Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Obstet Gynecol ; 191(1): 292-7, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15295381

RESUMO

OBJECTIVE: This study was undertaken to evaluate the pregnancy and perinatal outcomes of pregnant women with severe acute respiratory syndrome (SARS). STUDY DESIGN: All pregnant women (12) who presented with SARS in Hong Kong between February 1 and July 31, 2003, were included. The pregnancy and perinatal outcomes were collected. Evidence of perinatal transmission of virus was assessed with the SARS-associated coronavirus reverse-transcriptase polymerase chain reaction on cord blood, placenta tissue, and subsequent follow-up of the neonate on serology. RESULTS: Three deaths occurred among the 12 patients, giving a case fatality rate of 25%. Four of the 7 patients (57%) who presented in the first trimester had spontaneous miscarriage. Four of the 5 patients who presented after 24 weeks were delivered preterm. Two mothers recovered without delivery, but their ongoing pregnancies were complicated by intrauterine growth restriction. No newborn infant had clinical SARS and all investigations were negative for SARS. CONCLUSION: SARS during pregnancy is associated with high incidences of spontaneous miscarriage, preterm delivery, and intrauterine growth restriction. There is no evidence of perinatal SARS infection among infants born to these mothers.


Assuntos
Complicações Infecciosas na Gravidez , Resultado da Gravidez , Síndrome Respiratória Aguda Grave/complicações , Aborto Espontâneo/virologia , Adulto , Feminino , Retardo do Crescimento Fetal/virologia , Hong Kong , Humanos , Recém-Nascido , Transmissão Vertical de Doenças Infecciosas , Trabalho de Parto Prematuro/virologia , Gravidez , Complicações Infecciosas na Gravidez/fisiopatologia , Primeiro Trimestre da Gravidez , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Coronavírus Relacionado à Síndrome Respiratória Aguda Grave/isolamento & purificação , Síndrome Respiratória Aguda Grave/diagnóstico , Síndrome Respiratória Aguda Grave/transmissão
2.
Pediatrics ; 112(4): e254, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14523207

RESUMO

Severe acute respiratory syndrome (SARS) is a newly discovered infectious disease caused by a novel coronavirus. During the community outbreak in Hong Kong, 5 liveborn infants were born to pregnant women with SARS. A systematic search for perinatal transmission of the SARS-associated coronavirus, including serial reverse transcriptase-polymerase chain reaction assays, viral cultures, and paired serologic titers, failed to detect the virus in any of the infants. In addition, none of the infants developed clinical, radiologic, hematologic, or biochemical evidence suggestive of SARS. One preterm infant developed jejunal perforation and another developed necrotizing enterocolitis with ileal perforation shortly after birth. This case series is the first report to describe the clinical course of the first cohort of liveborn infants born to pregnant women with SARS.


Assuntos
Transmissão Vertical de Doenças Infecciosas , Complicações Infecciosas na Gravidez/virologia , Síndrome Respiratória Aguda Grave/transmissão , Adulto , Anti-Inflamatórios/efeitos adversos , Anti-Inflamatórios/uso terapêutico , Antivirais/efeitos adversos , Antivirais/uso terapêutico , Cesárea , Estudos de Coortes , Surtos de Doenças , Enterocolite Necrosante/etiologia , Feminino , Retardo do Crescimento Fetal/etiologia , Hong Kong/epidemiologia , Humanos , Doenças do Íleo/etiologia , Recém-Nascido , Recém-Nascido Prematuro , Perfuração Intestinal/etiologia , Doenças do Jejuno/etiologia , Masculino , Metilprednisolona/efeitos adversos , Metilprednisolona/uso terapêutico , Gravidez , Complicações Infecciosas na Gravidez/tratamento farmacológico , Complicações Infecciosas na Gravidez/epidemiologia , Síndrome do Desconforto Respiratório do Recém-Nascido/complicações , Ribavirina/efeitos adversos , Ribavirina/uso terapêutico , Coronavírus Relacionado à Síndrome Respiratória Aguda Grave/isolamento & purificação , Síndrome Respiratória Aguda Grave/tratamento farmacológico , Síndrome Respiratória Aguda Grave/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...